Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

COMPLETED
NAC to Prevent Cisplatin-induced Hearing Loss
Description

Cisplatin is a key chemotherapy agent for the treatment of multiple childhood cancers but causes permanent hearing loss. This study investigates the drug N-acetylcysteine (NAC) to determine the dose necessary to protect hearing and also how well tolerated NAC is when combined with chemotherapy.